Glyka MR Diabetes Gliclazide Modified Release Tablets 30mg 30s

• Oral anti‑diabetic medication • Contains Gliclazide 30mg (modified release) • Used to control blood glucose in Type 2 diabetes • Once‑daily dosing • Pack contains 30 tablets • Helps improve insulin secretion • Suitable for adults only

• Glyka MR 30mg contains Gliclazide in a modified‑release formulation designed to provide steady glucose control throughout the day • Helps reduce blood sugar levels by stimulating insulin release from pancreatic beta cells • Used as part of diabetes management along with diet and exercise • Designed to minimize fluctuations in blood glucose • Often prescribed when lifestyle changes alone are insufficient • Should be taken at the same time each day, usually with breakfast Benefits • Provides stable blood glucose control • Once‑daily convenience • Helps reduce risk of diabetes‑related complications • Supports consistent insulin secretion • Modified‑release formula reduces peaks and drops in glucose levels • Can be used alone or with other anti‑diabetic medications How to Use • Take one tablet daily or as prescribed by a physician • Swallow whole, do not crush or chew • Take with food, preferably breakfast • Follow prescribed diet and exercise plan • Monitor blood glucose regularly • Not recommended for children or Type 1 diabetes